13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 39 holding rows worth $369,103,000.
- Accession
- 0001387131-19-003635
- Filer
- CIK 1595851
- Filed
- 2019-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, 39 entries on the cover page, a total value of $369,103,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $369,103,000 with VALUE read as thousands by filing date, 13F file number 028-16059. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 385,000 | $45,315,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 900,000 | $24,165,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 240,000 | $19,212,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,300,000 | $17,680,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 300,000 | $15,879,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 800,000 | $15,368,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 80,000 | $14,716,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 150,000 | $14,018,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 75,000 | $11,929,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 400,000 | $11,448,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 500,000 | $11,315,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 150,000 | $10,995,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,150,000 | $10,937,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 600,000 | $10,524,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 750,000 | $9,960,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 185,000 | $9,250,000 | thousands by filing date | put |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 700,000 | $8,799,000 | thousands by filing date | |
| INVESCO CURRENCYSHARES SWISS | 46138R108 | SWISS FRANC | 91,800 | $8,574,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 115,000 | $8,401,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 175,000 | $7,875,000 | thousands by filing date | call |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 500,000 | $7,265,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 175,000 | $6,829,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 300,000 | $6,720,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 850,000 | $6,554,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 500,000 | $6,195,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 450,000 | $6,138,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 150,000 | $5,793,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 2,100,000 | $5,544,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 750,000 | $5,543,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 300,000 | $5,364,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 310,000 | $4,411,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 500,000 | $4,070,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 700,000 | $3,640,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 175,000 | $2,583,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 200,000 | $2,558,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 2,000,000 | $1,180,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 100,000 | $920,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 100,000 | $811,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 11,500 | $625,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-19-003635 | this filing | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001387131-20-003803 | base | 2020-04-09 | acceptance time not in the bulk data set |